4-phenylbutyric acid has been researched along with Erythema in 1 studies
4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Srivastava, RK | 1 |
| Li, C | 1 |
| Weng, Z | 1 |
| Agarwal, A | 1 |
| Elmets, CA | 1 |
| Afaq, F | 1 |
| Athar, M | 1 |
1 other study available for 4-phenylbutyric acid and Erythema
| Article | Year |
|---|---|
Defining cutaneous molecular pathobiology of arsenicals using phenylarsine oxide as a prototype.
Topics: Animals; Arsenicals; Cell Line; Cells, Cultured; Edema; Endoplasmic Reticulum Chaperone BiP; Erythem | 2016 |